🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/08/2007 | 24,37 | 24,40 | 23,06 | 23,13 | -5,21% | 5,53% | 105.504 |
| 24/08/2007 | 24,22 | 24,63 | 23,58 | 24,40 | +0,77% | 4,33% | 145.686 |
| 23/08/2007 | 24,25 | 24,70 | 23,92 | 24,22 | +0,78% | 3,24% | 175.689 |
| 22/08/2007 | 24,03 | 24,52 | 23,09 | 24,03 | +1,10% | 5,92% | 213.546 |
| 21/08/2007 | 22,94 | 23,92 | 22,61 | 23,77 | +4,44% | 5,71% | 135.347 |
| 20/08/2007 | 23,17 | 23,47 | 22,53 | 22,76 | -1,14% | 4,04% | 139.995 |
| 17/08/2007 | 23,51 | 23,54 | 22,53 | 23,02 | +2,50% | 4,30% | 220.920 |
| 16/08/2007 | 22,98 | 23,21 | 21,45 | 22,46 | -1,96% | 7,65% | 292.601 |
| 15/08/2007 | 22,87 | 23,96 | 22,65 | 22,91 | +0,33% | 5,73% | 329.042 |
| 14/08/2007 | 22,53 | 23,54 | 22,46 | 22,83 | +2,01% | 4,82% | 170.586 |
| 13/08/2007 | 23,66 | 24,70 | 21,63 | 22,38 | -3,24% | 12,97% | 215.817 |
| 10/08/2007 | 22,83 | 23,99 | 21,97 | 23,13 | +1,31% | 8,85% | 171.254 |
| 09/08/2007 | 22,94 | 24,89 | 22,31 | 22,83 | -2,40% | 11,26% | 497.678 |
| 08/08/2007 | 21,86 | 27,55 | 21,19 | 23,39 | +10,62% | 29,11% | 539.597 |
| 07/08/2007 | 20,21 | 21,75 | 19,88 | 21,15 | +5,41% | 9,26% | 290.490 |
| 06/08/2007 | 20,10 | 21,67 | 19,46 | 20,06 | +3,28% | 10,99% | 349.000 |
| 03/08/2007 | 21,15 | 21,34 | 19,43 | 19,43 | -7,32% | 9,03% | 389.716 |
| 02/08/2007 | 21,19 | 21,63 | 20,47 | 20,96 | -1,06% | 5,48% | 357.202 |
| 01/08/2007 | 19,99 | 21,37 | 19,73 | 21,19 | +4,81% | 8,24% | 484.480 |
| 31/07/2007 | 21,11 | 21,78 | 20,14 | 20,21 | -2,53% | 7,80% | 122.523 |
| 30/07/2007 | 22,16 | 22,38 | 20,51 | 20,74 | -6,89% | 8,45% | 390.972 |
| 27/07/2007 | 23,09 | 23,84 | 21,63 | 22,27 | -4,03% | 9,56% | 333.531 |
| 26/07/2007 | 24,52 | 24,74 | 22,79 | 23,21 | -5,77% | 7,94% | 264.201 |
| 25/07/2007 | 24,67 | 25,00 | 24,33 | 24,63 | +0,46% | 2,73% | 161.850 |
| 24/07/2007 | 25,75 | 25,90 | 24,33 | 24,52 | -5,35% | 6,10% | 181.005 |
| 23/07/2007 | 26,09 | 26,20 | 25,41 | 25,90 | -0,72% | 3,01% | 260.461 |
| 20/07/2007 | 25,86 | 26,58 | 25,64 | 26,09 | +1,60% | 3,62% | 545.608 |
| 19/07/2007 | 25,15 | 26,01 | 24,48 | 25,68 | +1,78% | 6,10% | 233.317 |
| 18/07/2007 | 25,64 | 25,86 | 24,37 | 25,23 | -2,18% | 5,84% | 309.753 |
| 17/07/2007 | 25,90 | 26,16 | 25,45 | 25,79 | -0,43% | 2,75% | 118.969 |